Related Experiment Video
Updated: Sep 10, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
New-Onset Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting: Is Pulmonary Hypertension a Risk
1Inonu University Faculty of Medicine Department of Cardiovascular Surgery Malatya Turkey Department of Cardiovascular Surgery, Faculty of Medicine, Inonu University, Malatya, Turkey.
Pulmonary hypertension and elevated pulmonary artery pressure are significant risk factors for new-onset atrial fibrillation after coronary artery bypass grafting surgery. Identifying these predictors aids in preventing this common complication.
Area of Science:
- Cardiology
- Thoracic Surgery
- Critical Care Medicine
Background:
- Postoperative new-onset atrial fibrillation (NOAF) is a common complication following cardiac surgery.
- Pulmonary hypertension (PH) is increasingly recognized as a significant comorbidity in cardiovascular disease.
Purpose of the Study:
- To investigate whether pulmonary hypertension is an independent risk factor for NOAF after isolated coronary artery bypass grafting (CABG).
- To identify clinical predictors of NOAF in patients undergoing CABG.
Main Methods:
- Retrospective analysis of 854 patients undergoing isolated CABG with preoperative pulmonary artery pressure (PAP) measurement.
- Comparison of demographic, clinical, and treatment parameters between patients with and without post-CABG NOAF.
- Multivariate regression analysis to identify independent predictors of NOAF.
Main Results:
- Elevated mean systolic PAP (OR: 1.027) and the presence of PH (≥ 30 mmHg, OR: 1.659) were independent risk factors for post-CABG NOAF.
- Other identified risk factors included older age, higher EuroSCORE, chronic obstructive pulmonary disease (COPD) (OR: 2.033), and longer ventilation support duration (OR: 1.059).
Conclusions:
- Increased PAP and PH are significant predictors of NOAF post-CABG.
- Identifying patients with PH and other risk factors like COPD can guide preventative strategies for NOAF.
- Further prospective studies are needed to validate these findings.
More Related Videos
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization II: Right Heart Catheterization
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

